The role of neoadjuvant chemoradiotherapy in resectable pancreatic cancer

被引：0
|
作者：
Kim, H. J. [1 ]
Bang, S. [1 ]
Park, S. W. [1 ]
Chung, J. B. [1 ]
Song, S. Y. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A138 / A138
页数：1
相关论文
共 50 条
  • [1] The Role of Neoadjuvant Chemoradiotherapy for Potentially Resectable Pancreatic Cancer
    Kim, Yoon Jae
    Choi, Jin-Young
    Chung, Yong Eun
    Kim, Hee Man
    Park, Semi
    Kim, Hong Jeoung
    Hong, Sung Pil
    Seong, Jinsil
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Bang, Seungmin
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [2] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    [J]. UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [3] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    [J]. Updates in Surgery, 2016, 68 : 235 - 239
  • [4] Neoadjuvant chemoradiotherapy for resectable pancreatic cancer
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 392 - 392
  • [5] Role of Chemoradiotherapy in the Adjuvant and Neoadjuvant Settings for Resectable Pancreatic Cancer
    Sen, N.
    Falk, S.
    Abrams, R. A.
    [J]. CLINICAL ONCOLOGY, 2014, 26 (09) : 551 - 559
  • [6] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [7] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [8] Role of Short-Term Neoadjuvant Chemoradiotherapy for Potentially Resectable Pancreatic Cancer
    Okano, Keiichi
    Suto, Hironobu
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Kamada, Hideki
    Kobara, Hideki
    Masaki, Tsutomu
    Suzuki, Yasuyuki
    [J]. AMERICAN SURGEON, 2022, 88 (06) : 1298 - 1303
  • [9] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 11
  • [10] Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer
    Lee, Darren
    Nelson, Bailey
    Rai, Shesh
    Rai, Jayesh
    Wang, Kyle
    Sohal, Davendra
    Olowokure, Olugbenga Olanrele
    Rojan, Adam
    Patel, Sameer H.
    Wilson, Gregory
    Ahmad, Syed A.
    Kharofa, Jordan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345